Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07798037
NA

Iatrogenic Atrial Septal Defect Gradient for Intraprocedural Success After M-teer

Sponsor: Hippocration General Hospital

View on ClinicalTrials.gov

Summary

Transcatheter mitral edge-to-edge repair (M-TEER) has become an established minimally invasive therapy for patients with severe mitral regurgitation (MR) who are at high or prohibitive surgical risk. However, accurate quantification of residual MR after M-TEER remains challenging. In this direction, the hemodynamic significance of the post-procedural iatrogenic atrial septal defect (iASD) gradient is unknown. The objective of this study is to assess the relationship between the post-procedural iASD pressure gradient and the severity of residual MR with intraprocedural echocardiographic and hemodynamic parameters.

Official title: Iatrogenic ASD Gradient as a Marker of Residual Mitral Regurgitation Severity After M-TEER Procedure

Key Details

Gender

All

Age Range

40 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2024-09-09

Completion Date

2028-06-10

Last Updated

2026-09-01

Healthy Volunteers

No

Interventions

PROCEDURE

M-TEER

Hemodynamic and echocardiographic assessment of M-TEER procedural success

Locations (1)

First Cardiology Department, Hippokration General Hospital

Athens, Greece